For Quick Alerts
Subscribe Now  
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Fortis HC to buy the promoter owned Fortis HC International

Fortis Healthcare to buy promoter owned company
Fortis Healthcare took to downward movement after the company's board approved the resolution to acquire Fortis International, a Singapore-based leading integrated healthcare delivery company, under an all-cash deal.

This entity, Fortis Healthcare International, is owned by RHC Financial Services (Mauritius), a company that in turn is owned by the promoters of Fortis Healthcare India.

In its filing on the Bombay Stock Exchange, the company said: "The Board has also decided, subject to necessary approvals, to change the name of Fortis Healthcare India to Fortis Healthcare Ltd ('Fortis Healthcare')."

Some analysts' were of the view that if investors owned the stock then they should remain invested in it or fresh positions should be taken if the stock dips further.

On the other hand the reaction of the market was more on the lines of suspicious. Since both the companies are owned by the same promoters, an all cash deal does make the entire thing a little questionable, even though the company has stated its intent to hire a third party to conduct the valuation.

"The valuation will be advised by an independent valuation agency,to be appointed by a committee of Independent Directors for the purpose," said the company in its report.

Reports have stated that Fortis Healthcare India, promoted by the Singh brothers, will invest $1 billion over the next 3 years. This entity will will have total revenue of $1 billion.

The combined network will have over 74 hospitals with more than 12,000 beds, 580 primary care centers, 188 day care specialty centers, 190 diagnostic centers and a base of over 23,000 employees, making it amongst the largest integrated healthcare delivery networks in Asia Pacific.

VIEW: The technical charts show that the Stochastics have fallen by 75 and the direction of the stochastic oscillator is downard. The stock will have resisitance at Rs 142. If it falls below that then it will get its support at Rs 133. On the volume front also there is a decreasing trend.

We would recommend investors to stay away from the stock till it comes out with the valuation report on Fortis Healthcare International.

GoodReturns.in DISCLAIMER: The views expressed in this article are the views of the author and do not reflect the views of our company. GoodReturns.in does not take any responsibility for any losses incurred by investors who take their cues from the above article

Story first published: Monday, September 19, 2011, 15:39 [IST]

Advertisement

Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X